International life science expansion where it truly matters:
the strategy to move wisely, the capital to act without compromise, and the right connections to go far.
Read about our commitment to our international partners
Go far, go fast, and go with the right people
Strategy
We provide education and 1:1 strategic work to help scaleups lower their commercial risk as they enter the US.
Scale
SCALE matches highly relevant scaleups with US strategic partners in clinical workflow for mutual benefits.
Capital
The Venture Atlas Labs Capital Network reviews, conducts due diligence, and syndicates early-stage deals monthly.
Leveling the playing field for
resilience and impact
Most focus on getting you in the game: regulatory, reimbursement, legal setup, payroll.
It’s important, but it’s table stakes. To win, you need a viable strategy, commercial partners, and funding that works for you.
We address the critical areas that cost international scaleups the most—very different business models, a very long sales cycle with high commercial risk, and difficulty raising sufficient operating capital.
Instead, we’re focused on helping you succeed commercially—and by defining your strategy first, you can refine areas like regulatory pathways accurately the first time.
The US healthcare market is a spectrum of different models, some of which may highlight your unique value better than others—and some of which may be completely incompatible with your business.
We don’t want to cover up the perspectives and insights that made you successful abroad. We want to leverage them to your competitive advantage and to the advantage of our health systems, clinicians, and patients.
